Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-21
    E.g., 2018-10-21

Archive Search

Pages

27 items
12:00 PM, May 04, 2018  |  BC Week In Review | Financial News  |  Postponed Offerings

Alzheimer's company Alzheon postpones IPO

Alzheon Inc. (Framingham, Mass.) has postponed its IPO, according to a statement to BioCentury. In March, the Alzheimer's disease company had filed for a listing on NASDAQ underwritten by Citigroup, Piper Jaffray, Canaccord Genuity and...
12:00 AM, Oct 31, 2016  |  BC Week In Review | Financial News  |  Postponed Offerings

Northwest Biotherapeutics postpones direct public offering

Northwest Biotherapeutics Inc. (NASDAQ:NWBO), Bethesda, Md.  Business: Cancer  Date announced: 2016-10-27  Type: Direct public offering  Placement agent: Roth Capital Partners  Investor: Institutional investor  Note: Northwest Biotherapeutics postponed the completion of its $5.3 million registered direct offering, which the company proposed on...
12:00 AM, Aug 15, 2016  |  BC Week In Review | Financial News  |  Postponed Offerings

Motif Bio postpones follow-on

Motif Bio plc (LSE:MTFB), London, U.K.   Business: Infectious   Date announced: 2016-08-09   Type: Follow-on   Underwriters: SunTrust; Ladenburg Thalmann   Note: Motif postponed its follow-on to list its ADSs on NASDAQ, citing market conditions. In late July, the...
12:00 AM, Jul 25, 2016  |  BC Week In Review | Financial News  |  Postponed Offerings

Heat Biologics postpones follow-on

Heat Biologics Inc. (NASDAQ:HTBX), Durham, N.C.   Business: Cancer, Infectious   Date announced: 2016-07-22   Type: Follow-on   Underwriter: Joseph Gunnar   Note: Heat Biologics suspended its follow-on the day after proposing it. The company says it will explore alternative...
12:00 AM, Oct 26, 2015  |  BC Week In Review | Financial News  |  Postponed Offerings

Acacia Pharma postpones IPO

Acacia Pharma plc, Cambridge, U.K.   Business: Gastrointestinal, Endocrine/Metabolic, Other   Date announced: 2015-10-16   Type: IPO   Underwriters: JPMorgan; Canaccord   Note: Acacia Pharma postponed its IPO on the London Stock Exchange, citing market conditions. The company proposed to...
12:00 AM, Oct 19, 2015  |  BC Week In Review | Financial News  |  Postponed Offerings

Shield Therapeutics postpones IPO

Shield Therapeutics AG, Wollerau, Switzerland   Business: Hematology   Date announced: 2015-10-05   Type: IPO   Underwriters: Investec; Canaccord; RBC Capital Markets   Note: Shield Therapeutics postponed its IPO on the London Stock Exchange, citing market conditions. The company proposed...
12:00 AM, May 18, 2015  |  BC Week In Review | Financial News  |  Postponed Offerings

Gelesis postpones IPO

Gelesis Inc., Boston, Mass.   Business: Endocrine/Metabolic   Date announced: 2015-05-13   Type: IPO   Underwriters: Piper Jaffray; Stifel, Nicolaus; Guggenheim Securities   Note: Gelesis postponed its IPO on NASDAQ. In late April, the company amended the offering and proposed...
12:00 AM, Mar 02, 2015  |  BC Week In Review | Financial News  |  Postponed Offerings

Infraredx postpones IPO

Infraredx Inc., Burlington, Mass.   Business: Diagnostic   Date announced: 2015-02-23   Type: IPO   Underwriters: RBC Capital Markets; Canaccord; BMO Capital Markets; Oppenheimer; BTIG   Note: Infraredx postponed its IPO. In January, the company amended its offering and planned...
12:00 AM, Feb 09, 2015  |  BC Week In Review | Financial News  |  Postponed Offerings

Advanced Accelerator Applications postpones IPO

Advanced Accelerator Applications S.A., Saint Genis Pouilly, France   Business: Diagnostic, Cancer   Date announced: 2015-02-05   Type: IPO   Underwriters: Citigroup; Jefferies; Canaccord; JMP Securities   Note: Advanced Accelerator postponed its IPO on NASDAQ. Last month, the company said...
12:00 AM, Oct 27, 2014  |  BC Week In Review | Financial News  |  Postponed Offerings

Molecular Partners postpones IPO

Molecular Partners AG, Schlieren, Switzerland   Business: Ophthalmic, Cancer, Inflammation   Date announced: 2014-10-21   Type: IPO   Underwriters: JPMorgan; UBS; Cowen; Bank am Bellevue   Note: Molecular Partners postponed its IPO on SIX Swiss Exchange, citing market conditions.   ...

Pages